EPAM vs VERA · P/E 14, rev $2.81B vs $2.51B cap
EPAM Systems Inc (EPAM) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
VERA does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. VERA currently screens at market cap $2.51B.
Not investment advice. Open the EPAM and VERA stock pages for the full models.
Not investment advice.